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     SUMMARY
Background: A valid scientific evaluation of the efficacy of HIV vaccines or antiretroviral 
drugs includes measurement of changes in physiological parameters of subjects from known 
established baseline reference ranges. This study was designed to establish reference ranges for 
biochemical parameters among healthy adult Cameroonians to support planned HIV Vaccine 
clinical trials and scaling up of ARV drugs among AIDS patients. 
Methods: After informed consent, blood and urine samples were collected from a total of 576 
adult Cameroonians and analyzed for the presence of underlying pathologies that may affect 
biochemical parameters. Samples from 501 of them were found eligible for the determination 
of reference biochemical parameters.  After complete assay, the data were subjected to both 
parametric and non parametric statistics for analyses with 2.5 and 97.5 percentiles considered 
as the lower and upper limits of reference ranges. 
Results: There were 331(66.1%) males and 170(33.9) females, with 359(71.7%) and 142(28.3) 
of them residing in the urban and rural areas respectively. Statistically significant differences 
(P<0.05) were observed in the following biochemical parameters between urban and rural 
participants: AST, ALT, alkaline phosphatase, creatinine, total protein, albumin, triglyceride, 
total cholesterol, and the bilirubins. When the data were regrouped into sex, there were 
statistically significant differences (P<0.05) in the following parameters between males and 
females: AST, ALT, creatinine, albumin, triglyceride, total cholesterol, and direct bilirubin. 
Conclusion: The present study shows that sex and geographic location have significant impact 
on reference physiological biochemical parameters of healthy, adult Cameroonians; hence this 
should be taken into consideration when monitoring participants either during HIV Vaccine 
clinical trials or on antiretroviral (ARV) drugs treatment. 
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Introduction
The human immunodeficiency virus (HIV) constitutes 
a major public health problem in Cameroon with a 
prevalence rate of 5.5% [1]. Furthermore, Cameroon 
has been identified worldwide as the country with the 
highest HIV heterogeneity; in fact the HIV-1 group N 
has been reported only among Cameroonians [2, 3]. In 
addition, it is suspected that the virus was 
initially transmitted from chimpanzees to humans in 
Cameroon, where the emergence of the AIDS pandemic 
occurred [4]. Therefore current international efforts to 
develop an effective and affordable preventive HIV 
Vaccine will necessary pay attention to Cameroon in 
choosing appropriate populations for clinical trials. 
Indeed, Cameroon is at the moment one of the African 
countries that is building capacity for HIV Vaccine 
trials. It has gone into partnership with leading 
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international organisations such as the United States 
based Centers for Disease Control and Prevention 
(CDC), the Department of Defence (DoD), and the 
WHO/UNAIDS-AAVP in efforts to bring this initiative 
to fruition.  Such vaccine trials require a platform for 
clinical evaluation of safety and efficacy. Further, since 
the start of antiretroviral drug use in Cameroon, there 
has been a great need for a platform for the evaluation 
of the efficacy of treatment efforts. This will be timely 
particularly at this point when the Cameroon National 
AIDS Control Program is scaling up antiretroviral 
drug treatment among AIDS patients nationwide. 
This platform for scientific and clinical validation 
of HIV Vaccines and antiretroviral drugs in Cameroon 
would be based on reference ranges for given 
parameters of clinical interest. Such reference ranges 
are defined as the concentration of these parameters in a 
group of clinically healthy persons [5,6]. Under normal 
physiological conditions, haemostatic mechanisms 
keep these parameters within a certain limit [6]. In 
healthy individuals they vary considerably in different 
populations [5,7]. In body fluids, and in the absence of 
diseases, they are influenced by several factors such 
as age, sex, dietary habits of the people, geographical 
location and climate [8,9,10,11,12,,13,14,]. Further, 
several of these parameters show diurnal and seasonal 
variations [2]. They may also change as a result of 
variation in techniques used by different laboratories 
[15,16,11,17].
The parameters can also vary following pathological 
conditions that affect major body organs and systems 
that produce, secret or store them such as the Liver, 
Pancreas, Kidney, Bone marrow and the Immune 
system [18,19,20]. Administration of drugs or vaccines 
for therapeutic purposes or clinical trials can also cause 
significant variations [2]. The timely measurement of 
these parameters is therefore absolutely necessary 
in the evaluation of either disease state or prognosis 
following therapeutic or clinical interventions.
Reference ranges for Biochemical parameters 
are non-existent in Cameroon where, like in many 
other countries of the third world, it is common 
practice to use reference ranges established for 
Western populations for interpretation of laboratory 
results. There is therefore need for baseline reference 
laboratory ranges with which to monitor not only 
physiological or pathological changes following 
administration of various drugs and vaccines to healthy 
persons in Cameroon, but also disease states following 
infectionwith various pathogens. The reference 
ranges we have established here set the stage for the 
development of a framework to meet these goals.  
Methods
Study Design and Population
This was a cross sectional study that recruited 
participants from both urban and rural communities 
with diverse backgrounds. The rural participants 
were recruited at the Shamka Foundation health unit 
located in the rural village of Ekorezok in Nkolbisson 
some 15 kilometres from Yaounde. This village holds 
a population of about 30,000 inhabitants. The staple 
food is mainly cassava leaves (nqwem), groundnuts 
and cassava itself in different forms. The area is 
surrounded by water and inhabitants depend on the 
mud-fish from these streams for supplementing their 
diet. Inhabitants of this locality who responded to the 
Foundation’s health unit call for people to come for 
HIV/AIDS voluntary counselling and testing during 
the December 2006 World AIDS week, were consented 
and included in the study. The urban study samples 
were collected from the city of Yaounde. This is the 
capital of Cameroon. It has a population estimate of 
about one and a half million inhabitants. As a capital 
city, it hosts populations from diverse backgrounds, 
mostly of the higher and middle income earning 
bracket with typical life styles and nutritional habits 
different from those in the rural areas. Participants 
were identified from apparently healthy people who 
came to donate blood at the blood transfusion unit of 
the University of Yaounde Teaching Hospital (CHU). 
All consenting participants between the ages of 18 
and 59 years from both the urban and rural areas were 
included in the study. A lower age of 18 years was 
used because this is the minimum age of independent 
consent in Cameroon. We limited the upper age at 
59 years because above this age, body physiological 
parameers start deviating; further, people above this 
age would not be good candidates for clinical trials.
Laboratory Procedures:
After appropriate informed consent and a structured 
interview that solicited information on socio-
demographic and medical history, about 10mls whole 
blood was collected from overnight fasted participants 
by trained phlebotomists. This was aliquoted into 
various blood collection tubes as follows: a portion 
was put into the K-EDTA tube for detection of HIV, 
Malaria parasite and Hepatitis B. The remaining 
portion was put in sterile plain tubes and allowed to 
clot for 4 – 6 hrs before the serum was prepared by 
centrifugation at 3000 rpm for 30 minutes. The serum 
samples were aliquoted and stored at – 20°C until 
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used for measurement of biochemical parameters. For 
urine collection, participants provided the samples in 
appropriately labelled containers given to them by us.
Screening for Exclusion from the study:
HIV serology was done using two rapid test kits, 
Determine (Abbott Laboratories, Abbott Park, IL ) 
and OraQuick (Ora-Sure Technology Inc). Discordant 
samples were further tested using a tie-breaker; 
CAMSTIC (MINRESI, Yaounde); such samples that 
were positive with CAMSTIK were considered positive 
while those tested negative were considered negative. 
The thick blood film method was used to diagnose 
infection with malaria parasites; pregnancy and 
glucose were detected in urine by dipstick (Accurate 
and Medi – Test Combi 9). Hepatitis B surface antigen 
was detected by serology (Murex Abbott). Participants 
with the following outcomes that could affect the 
serum biochemical parameters were excluded from the 
study: pregnancy, HIV-positive status, Hepatitis B/C 
infection, Malaria and Urine glucose. Those diagnosed 
HIV-positive were orientated to Care and Treatment 
Centers after appropriate post test counselling and 
follow-up. 
Biochemical Estimation of Reference Ranges 
All Serum biochemical parameters were assayed 
by spectophotometry using kits from various 
manufacturers as indicated: Serum Aspartate 
aminotransferase (Orgernon, S.A, Spain), Serum 
Alanine aminotransferase (Quimica Clinica Aplicada, 
S.A, Spain), Alkaline phosphatase (Quimica Clinica 
Aplicada, S.A, Spain), Total and direct bilirubin 
(Human, Germany), Creatinine (Quimica Clinica 
Aplicada, S.A, Spain), Total and high density 
lipoprotein cholesterol (Quimica Clinica Aplicada, 
S.A, Spain), Triglycerides (Elitech, France),  Albumin 
and Total protein (Human, Germany).
Quality Assurance/Quality Control
To ensure the reproducibility and repeatability of 
the test results, all pre-analytic, analytical and post-
analytical precautions were taken into consideration. 
For example, all Standard Operating Procedures 
(SOPs) were reviewed for accuracy, all guidelines for 
sample collection, processing, storage and handling 
were strictly adhered to; instruments, personnel and 
procedure validation were carried out through an 
internal quality control (QC) program in which several 
samples were assayed through intra and inter daily 
laboratory runs with the calculation of standard 
deviations (SD) and coefficient of variations (CV) 
before the start of the study. Daily sample runs were 
usually done with blinded samples whose values were 
known only to the quality control officer. 
Statistical analysis
Statistical analyses were done using STATA version 
9.2 (Statacorp., Texas, USA). Means and standard 
deviations were calculated for normally distributed 
continuous data. Means were compared using the t-test 
or the Kruskal Wallis test. Medians and, the 25th and 
75th percentiles were also computed for the laboratory 
parameters. To compare the differences in the medians 
of sub-groups of the populations, Mann Whitney’s 
U-test was performed. To further quantify the spread 
of the data for each of the laboratory parameters, the 
2.5th and the 97.5th percentiles have been presented.
Ethical Approval
The study was approved by the Ethics committee of 
the Ministry of Public Health of Cameroon and the 
Institutional Review Board (IRB) of the Faculty of 
Medicine and Biomedical Sciences, University of 
Yaounde [1].
Summary of results
The mean ages, weights and heights of the entire pop-
ulation were 27.6 years, 71.5 kg and 1.7 meters re-
spectively. The males constituted 66.1% (328) while 
the females constituted 33.9% (168) of the total popu-
lation. Educational status of the participants was as 
follows:  GCE A/L (25.7%), GCE O/L (32.6%), First 
school leaving certificate (21.8%), and Bachelors de-
gree (21.0%) (Table I); 71.7 and 28.3% of them were 
recruited from the urban and rural areas respectively. A 
total of 576 participants were assessed for eligibility; 
75 of them were excluded and 501 were retained for 
sample analyses for various biochemical parameters 
(Table II). Apart from HDL cholesterol levels, there 
were significant differences in biochemical param-
eters between the urban and rural participants (Table 
III). There were statistically significant differences be-
tween males and females in the following biochemical 
parameters; AST, ALT, creatinine, albumin, triglyc-
eride, total cholesterol and direct bilirubin; however, 
values for alkaline phosphatase, total protein, HDL 
cholesterol and total bilirubin were not significantly 
different (Table IV). A comparison of ranges obtained 
in the present study and a similar study conducted in
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Rwanda is presented in table V while table VI shows a 
proposed reference physiological biochemical ranges 
among adult, healthy Cameroonians. 
Discussion
Reference ranges for biochemical parameters are non-
existent in Cameroon. Although some of these data ex-
ist for several studies, the supposed “normal subjects” 
were not usually controlled for confounding factors 
and results were not adequately analyzed and present-
ed in a format that was strong enough to assist various 
clinical and laboratory scientist when confronted with 
various problems that needed inferences to the normal 
population. To overcome these challenges, a sizeable 
representative population from both the urban and ru-
ral areas of Cameroon that met universally established 
inclusion criteria was used for the study. The demo-
graphic data collected (Table 1) truly mirrors infor-
mation that was obtained during the 2004 nationwide 
Demographic and Health Survey (DHS) [1], hence 
we are confident that these reported reference ranges 
gives a true reflection of the entire adult population of 
urban and rural areas of Cameroon.
Table I: Demographics Characteristics of participants
Characteristics (N=501)   Mean(SD)
Age (years)    27.6 (8.0)
Weight (kilograms)   71.5 (11.6)
Height (meters)    1.7(0.1)
Sex     n(%)
 Male    331(66.1)
 Female    170(33.9)
Education    n(%)
General certificate of education, 
advance level (GCE A/L)   120(25.7)
Bachelors degree    92(21.0)
General certificate of education, 
ordinary level (GCE O/L)   152(32.6)
First school leaving certificate  102(21.8)
Residential areas    n (%)
Urban     359( 71.7 )
Rural     142( 28.3 )
Table II: Sampling
Assessed for eligibility   576
Excluded    75
Eligible for Biochemical analysis  501
Reasons for exclusion  
Pregnancy    11
HIV-positive    36
Hepatitis B/C    9
Malaria     15
Urine glucose    4
Several underlying pathologies were identified that led 
to exclusion of certain participants from the study; this 
highlights the need to develop and keep to strict crite-
ria in the determination of normal or reference ranges 
of various populations (Table II). In the tropical con-
text, there has been some disagreement in relation to 
the definition of a normal individual because of the 
fact that in this region, it would be impossible to find 
an individual who does not harbor at least a single par-
asite. In line with this, there is the need to look at the 
clinical pathological implications of these parasites in 
relation to the parameters in question. For example, an 
inclusion criterion for a study that seeks to establish 
normal reference ranges for hematological parameters 
needs to target parasites that affect the hematological 
pictures, likewise for biochemical parameters; how-
ever, inclusion of parasite density would give clinical 
laboratory meaning to the results obtained. We com-
bined laboratory information with a good medical his-
tory of various participants to select individuals who 
were eligible for biochemical analysis.
In keeping with reports from similar studies that have 
been conducted in other countries, this study shows 
variations in several reference biochemical param-
eters between healthy Cameroonians by sex and by 
geographic location (Tables III, IV). As has been men-
tioned, several factors including sex, age, diet, and geo-
graphic location, significantly affect reference physi-
ological parameters in humans [8,9,10,11,12,13,14]. 
The description of the two localities and their popula-
tions show that these are completely distinct entities, 
thus justifying the significant differences in biochemi-
cal parameters amongst the populations. As a quality 
assurance measure, all necessary pre-analytical, ana-
lytical and post-analytical precautions were taken to 
ensure that these data were not biased or thwarted by 
any factors. The present study underpins the impor-
tance of considering reference ranges in relation to 
geographic location and sex. 
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Table III: Analysis of Overall Biochemical Parameters by Residential Area (urban/rural)
Parameter                                 Mean (SD)      Median   2.5th, 97.5th percentiles  P-value
   Urban (N=359) Rural (N=142) Urban Rural Urban  Rural 
AST (U/L)  21.3 (7.9) 15.7(5.1)  20.1 14.8 9.6 to 43.6 7.9 to 27.9 0.001
ALT (U/L)  12.4(6.7)  10.6(3.9)  11.1 9.6 5.2 to 31.4 5.7 to 19.7 0.023
Alkaline Phos (U/L)  111.4(51.3) 136.4(62.6) 102.1 122.4 46.9 to 206.1 60.1 to 297.6 0.001
Creatinine (mg/dl)  0.7(0.6)  0.7(0.7)  0.6 0.5 0.2 to 2.1 0.2 to 2.8 0.027
Total Protein (g/l)  71.7(15.8) 79.3(12.6) 70.5 78.3 45.3 to 107.8 58.4 to 103.8 0.001
Albumin (g/l)  43.7(8.4)  51.3(7.8)  43 50.5 29.0 to 60.0 36.3 to 70.2 0.001
Triglyceride (g/l)  1.0(0.8)  1.6(1.0)  0.8 1.3 0.1 to 3.3 0.2 to 4.5 0.001
HDL Chol (mg/dl)  101.7(28.8) 102.3(30.6) 97.0 98.0 55.0 to 172.0 47.2 to 186.0 0.840
Total Chol (mg/dl) 180(50)  220(60)  170 210 90 to 300 120 to 380 0.001
Total Bil (mg/dl)  1.2(0.6)  1.9(0.9)  1.0 1.8 0.4 to 2.7 0.7 to 4.6 0.001
Direct Bil (mg/dl)  0.5(0.3)  0.6(0.3)  0.4 0.6 0.1 to 1.2 0.2 to 1.4 0.001
Table IV: Analysis of Overall Biochemical Parameters by Sex (males/females)
Parameter                              Mean (SD)                 Median                               2.5th, 97.5th percentiles                P-value
                        Males (N=331)   Females (N=170)         Males Females        Males Females 
AST (U/L)  20.9(7.1)              17.4(7.9)            20.1  15.7      9.6 to 39.9 7.9 to 44.3 0.001
ALT (U/L)                 12.5(6.1)              10.7(5.9)             11.1    9.1      5.2 to 29.5 5.2 to 28.5 0.001
Alkaline Phos (U/L) 120.9(61.5)          113.7(42.4)          104.9  106.7      51.7 to 270.2 51.0 to 220.4 0.414
Creatinine (mg/dl) 0.7(0.5)              0.7(0.7)             0.6      0.5       0.2 to 2.2 0.2 to 2.3  0.004
Total Protein (g/l)                 73.8(15.6)           74.0(14.9)          71.9   72.0       46.1 to 107.9 47.4 to 102.4 0.921
Albumin (g/l)                 45.2(9.1)  47.1(8.4)  44.7    47.2       29.0 to 64.9 30.9 to 67.4 0.028
Triglyceride (g/l)  1.1(0.8)  1.3(1.0)  0.9    1.1       0.1 to 3.4 0.1 to 4.2  0.032
HDL Chol (mg/dl)  100.5(28.8) 104.5(30.1) 97.0    99.5       55.0 to 171.5 53.2 to 172.7 0.153
Total Chol (mg/dl) 180(50)  200(60)  180    190       90 to 310 90 to 350 0.001
Total Bil (mg/dl)  1.4(0.7)  1.3(0.8)  1.3    1.2       0.4 to 3.4 0.3 to 3.2  0.307
Direct Bil (mg/dl)  0.5(0.4)  0.5(0.3)  0.5    0.4       0.1 to 1.3 0.1 to 1.1                0.015
Table V: Comparison between Reference Biochemical Parameters of Cameroonians and Rwandans
Parameter Site                  Mean (SD)             Median         2.5th, 97.5th percentiles
    Males           Females        Males           Females Males              Females
AST (U/L) CMR  20.9(7.1)          17.4(7.9)       20.1                15.7 9.6 to 39.9             7.9 to 44.3
  RWD  31(19.3)           22 (8.1)       26  21 16 to 19                13 to 43
ALT (U/L) CMR  12.5(6.1)          10.7(5.9)      11.1  9.1 5.2 to 29.9             52.9 to 28.5
  RWD  31 (19.3)          21 (11.4)        22  19 9 to 58                8 to 48
Alkaline Phos (U/L) CMR  120.9(61.5)      113.7(42.4)     104.9  106.7 51.7 to 270.2        51.0 to 220.4  
  RWD  74 (17.6)           91  (33.8)      73  89 48 to 116              43 to 187 
Creatinine (mg/dl) CMR  0.7(0.5)             0.7(0.7)      0.6  0.5 0.2 to 2.2               0.2 to 2.3   
  RWD  0.8 (0.2)            0.7 (0.2)      0.8  0.7 0.5 to 1.2               0.4 to 1.1        
Total Protein (g/l) CMR  73.8(15.6)        74.0(14.9)     71.9  72.0 46.1 to 107.9         47.4 to 102.4
  RWD  70 (7.3)          70 (7.9)      69  70 57 to  84                54 to 86
Albumin (g/l) CMR  45.2(9.1)           47.1(8.4)      44.7  47.2 29.0 to 64.9           30.9 to 67.4 
  RWD  43 (3.9)             42 (4.2)      42  41 36 to 50   35 to 52
Triglyceride (g/l) CMR  1.1(0.8)             1.3(1.0)      0.9  1.1 0.1 to 3.4 0.1 to 4.2 
  RWD  NA           NA       NA  NA NA  NA
HDL Chol (mg/dl) CMR  100.5(28.8)      104.5(30.1)         97.0  99.5 55.0 to 171.5 53.2 to 172.7
  RWD  NA           NA       NA  NA NA  NA
Total Chol (mg/dl) CMR  180(50)          200 (60)      180  190 90 to 310  90 to 350
  RWD  NA                    NA       NA  NA NA  NA
Total Bil (mg/dl) CMR  1.4(0.7)             1.3(0.8)      1.3  1.2 0.4 to 3.4 0.3 to 3.2
  RWD  0.8 (0.5)           0.7 (0.3)      0.8  0.5 0.4 to 1.9 0.2 to 1.4
Direct Bil (mg/dl) CMR  0.5(0.4)           0.5(0.3)      0.5  0.4 0.1 to 1.3 0.1 to 1.1
  RWD  0.2 (0.1)           0.2 (0.1)      0.2  0.1 0 to 0.6   0 to 0.4
CMR= Cameroon (Present study)
RWD= Rwanda (Kayitenkore et al, 2005)
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The liver participates in a variety of metabolic 
activities such as detoxification and excretion 
of vaccines and drugs. Hence, any abnormal 
concentrations or constituents of these substances 
given to subjects will affect the liver’s architecture 
and be presented in the serum or plasma as abnormal 
levels of its metabolites such as enzymes and bilirubin. 
Statistically significant differences were observed 
in the serum levels of the liver aminotransferases 
(AST, ALT), alkaline phosphatise and bilirubin by 
sex and geographic located (Table III, IV). These are 
very important markers for assessing the functional 
integrity of the liver [7] hence the interpretation of 
their levels in the context of drug administration or 
vaccines should be done accordingly. Creatinine, a 
serum metabolic product of muscle creatine phosphate 
is the principal indicator of renal function. Being a 
product associated with the muscles, it usually shows 
sex differentials with women having lower levels than 
men due to lower body mass indexes [5,8,13]. The 
present study confirms this trend with both urban and 
rural males having significant higher levels of serum 
creatinine. Serum total proteins has in general been 
used to assess the state of hydration and nutritional 
status of individuals, hence its variations will usually 
reflects peoples’ lifestyles and habits [12,13]. The 
significantly higher protein levels observed in rural 
as compared to urban participants (Table III) are 
probably due to differences in their dietary habits with 
rural inhabitants having the opportunity of eating their 
traditional foods that may contain more proteins than 
the usual expensive artificial urban diets. A similar 
pattern was observed for serum albumin (Table III), a 
protein with a half life of 19 days usually used to 
differentiate cases of acute and chronic liver failures.   
Albumin also serves an additional function as a 
binding and transport protein for several substances 
including bilirubin and hormones [22]; hence its 
serum levels needs to be interpreted in relation to 
the concentrations of these binding substances. Rural 
participants had higher mean serum bilirubins (Table 
III) than their urban counterparts, thus confirming the 
observed serum albumin patterns. Several factors will 
influence changes in serum lipid levels. These include 
diet, sex, age, and lifestyle [8,9,10,11,12]. These could 
partly explain the significant and specific differences 
observed in both triglyceride and total cholesterol 
levels in the present study; however, the High Density 
Lipoprotein (HDL) cholesterol levels were similar in 
all categories (Tables VI). 
A literature search shows that there have been a 
lot of limitations on data generated in similar studies 
from other African countries. For example, sample 
sizes have been very limited, inclusion and exclusion 
criteria were poorly defined, and sex and residential 
identities were sometimes not highlighted. A very 
important weakness of several of these studies has 
also been the statistical analyses. Several biochemical 
parameters particularly the enzymes and lipids do not 
show Gaussian distribution; hence skewed data from 
these parameters can only be analysed and presented 
using non-parametric statistics. This has not been the 
case for several studies which imply that either data 
were poorly collected or several acceptable variables 
were erroneously eliminated in order to conveniently 
use parametric statistics in presenting the results. The 
only available study with similar methodology to the 
present study and whose results could be compared 
 Table VI: Proposed Reference Physiological Ranges for Plasma Biochemical Parameters among Adult Healthy Cameroonians    
     Urban                        Rural
     Males  Females Males  Females
 Parameter   2.5th to 97.5th     2.5th to 97.5th    2.5th to 97.5th    2.5th to 97.5th 
       percentiles     Percentiles    Percentiles     percentiles
 AST (U/L)    10.5 to 30.5     7.9 to 49.9    8.3 to 28.8    7.9 to 24.4
 ALT (U/L)    5.2 to 31.6                    5.1 to 36.5    5.5 to 18.1    5.1 to 36.6
 Alkaline Phos (U/L)  49.4 to 233     41.4 to 183    60.1 to 297.6    60.1 to 297.6
 Creatinine (mg/dl)   0.2 to 3.4     0.2 to 2.4    0.2 to 3.4    0.2 to 2.4
 Total Protein (g/l)    45.2 to 108     42.9 to 102    58.4 to 103.8    58.4 to 103.8
 Albumin (g/l)    29.0 to 61.7     30.1 to 58. 8    36.0 to 76.4    37.7 to 67.5
 Triglyceride (g/l)    0.1 to 3.4     0.1 to 2.4     0.1 to 5.0    0.2 to 4.7
 HDL Chol (mg/dl)    54.5 to 172.0     54.5 to 172.0    54.5 to 172.0    54.5 to 172.0
 Total Chol (mg/dl)   90 to 290     80 to 320    110 to 390    130 to 460
 Total Bil (mg/dl)    0.4 to 2.8     0.3 to 2.4    0.6 to 5.1    0.7 to 3.6
 Direct Bil (mg/dl)    0.1 to 1.2     0.3 to 2.4    0.1 to1.5    0.1 to 1.2
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within the African regions is that of Kayitenkore et al 
[13] from Rwanda (Table V). The data so presented 
shows similar patterns to those of the present study 
with variability in ranges that could be ascribed to 
differences in geographic region with particular 
underlying physiological factors that could influence 
their reference biochemical ranges. Other studies 
though not strongly comparable have also shown 
variations between reference ranges [15, 23,24].
Proposed reference ranges for biochemical 
parameters among healthy adult Cameroonians based 
on data generated from this study are presented in table 
VI. These ranges should be applied for various studies 
and research activities in Cameroon that apply strictly 
to these populations.
It is concluded that sex and geographic location 
have significant impact on reference physiological 
biochemical parameters of healthy, adult Cameroonians. 
Differences exist in reference ranges among adult, 
healthy Cameroonians and populations from similar 
Africa countries. There is need for similar studies 
that target the Paediatrics, Adolescent and Geriatric 
populations in Cameroon and other African countries.
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